Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
The Item 2.02 disclosure announces Diversified Healthcare Trust's financial results for the quarter ended June 30, 2026, with a summary press release (Exhibit 99.1) and detailed earnings presentation (Exhibit 99.2) attached. The filing includes key financial metrics such as net loss of $(37.4)M, Normalized FFO of $38.9M, Adjusted EBITDAre of $82.1M, and updated full-year 2026 guidance. This is a standard quarterly earnings release material to investors assessing the REIT's operational and financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.7
TotalEnergies announced second quarter and first half 2026 financial results, including adjusted net income of $6.0 billion and cash flow of $9.8 billion for Q2, with detailed segment performance, production figures, and forward guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This is a press release announcing Luckin Coffee's unaudited financial results for the second quarter ended June 30, 2026. The document discloses quarterly net revenues (RMB15.9 billion, up 28.5% YoY), GAAP operating income (RMB2.1 billion, up 22.0% YoY), net income (RMB1.5 billion, up 16.1% YoY), and key operating metrics including store count and customer growth. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
This is a clear earnings release disclosing Ocular Therapeutix's financial results for Q2 2026 (quarter ended June 30, 2026), filed on August 3, 2026 under Item 2.02. The press release reports total net revenue of $13.5 million, R&D expenses of $54.1 million, and a net loss of $(78.8) million, along with cash position of $598.6 million and runway into 2028. The disclosure is material as it provides investors with the company's quarterly financial performance and liquidity position.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This is a press release announcing Sportradar's second quarter 2026 financial results, including revenue of €378 million (up 19% YoY), Adjusted EBITDA of €76 million (up 19%), and updated full-year 2026 guidance. The disclosure presents quarterly financial performance metrics, operating highlights, and forward-looking revenue and EBITDA guidance, which are hallmarks of an earnings release. Material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Cohen & Company Inc. issued a press release on August 3, 2026, announcing financial results for the second quarter ended June 30, 2026. The disclosure includes revenue of $69.5 million, net income of $3.6 million ($0.94 per diluted share), and adjusted pre-tax income of $10.1 million ($1.62 per diluted share), along with a board declaration of a quarterly dividend of $0.25 per share. This is a standard quarterly earnings release filed under Item 2.02 with the earnings release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit discloses Fresenius Medical Care's Q2 2026 financial results, reporting operating income excluding special items of EUR 569 million (up 23% at constant currency) and group revenue of EUR 4,861 million (up 4% at constant currency), both exceeding market consensus expectations. The company also confirms its full-year 2026 outlook. This is a discrete earnings announcement for a quarterly period, material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This is a press release disclosing Fresenius Medical Care's Q2 2026 financial results, including revenue of EUR 4,861 million, operating income growth of 23% (adjusted), and EPS growth of 28% (adjusted). The document explicitly presents quarterly earnings figures, segment performance, cash flow metrics, and reaffirms the FY 2026 outlook—all hallmarks of an earnings release. Material to investors assessing the company's financial performance and strategic progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Matson, Inc. issued a press release on August 3, 2026 announcing second quarter 2026 earnings results, including net income of $129.4 million ($4.27 per diluted share), consolidated operating income of $158.9 million, and consolidated revenue of $969.4 million. The company also raised its full-year 2026 outlook. This is a standard quarterly earnings disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Vertex issued a press release on August 3, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing total revenues of $204.0 million (up 10.5% YoY), adjusted EBITDA of $51.0 million, and net income of $9.0 million, along with forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 7.01
Jackson Financial Inc. has furnished a slide presentation for its second quarter 2026 earnings call scheduled for August 4, 2026. The presentation discloses key financial results including GAAP earnings of $644M, non-GAAP earnings of $513M, earnings per share of $9.16 (GAAP) and $7.30 (non-GAAP), free cash flow of $287M, and capital return of $290M. This is a standard earnings release disclosure under Item 7.01 (Regulation FD Disclosure), with the detailed financial results and metrics presented in Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Lafayette Square USA, Inc. disclosed financial and performance information for the fiscal quarter ended June 30, 2026 via an investor presentation filed as Exhibit 99.1 under Item 2.02. The presentation includes consolidated statements of assets and liabilities, consolidated statements of operations for the three and six months ended June 30, 2026 and 2025, key performance metrics (total assets of $1.2B, NAV per share of $14.49, net investment income per share of $0.34 for Q2 2026), and per-share data including earnings per share and dividends declared. This is a standard quarterly earnings disclosure for a BDC.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing Grupo TMM's second quarter 2026 financial results, dated July 31, 2026. It discloses revenue of Ps.261.1 million, operating income of Ps.26.3 million, and net income of Ps.34.3 million for Q2 2026, along with complete balance sheet, income statement, and cash flow statements. The document explicitly states "GRUPO TMM REPORTS SECOND QUARTER 2026 RESULTS" and includes management commentary on operating performance and outlook, which is characteristic of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
New Jersey Resources issued a press release on August 3, 2026 reporting financial results for the third fiscal quarter ended June 30, 2026, with consolidated net income of $9.7 million ($0.10 per share) and year-to-date net income of $3.48 per share, along with tightened fiscal 2026 NFEPS guidance of $3.52–$3.62.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-03
Item 2.02
ON Semiconductor announced its second quarter 2026 financial results on August 3, 2026, disclosing revenue of $1,603.5 million (9% YoY growth), GAAP diluted EPS of $0.56, and non-GAAP diluted EPS of $0.74, along with detailed financial statements and forward guidance for Q3 2026. This is a standard quarterly earnings release filed under Item 2.02 with the earnings press release attached as Exhibit 99.1.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This is a press release announcing unaudited financial results for Q2 2026 and the six-month period ended June 30, 2026. The document discloses Q2 2026 Adjusted Net Income of $9.8 million ($0.40 per share), Net Income of $5.2 million ($0.21 per share), liquidity of $331.5 million, and operational updates including a vessel sale agreement and completion of the Cargill transaction. The disclosure includes financial highlights, a financial summary table with voyage revenue and earnings per share, and reconciliation of non-GAAP measures, all characteristic of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Integer Holdings issued a press release on August 3, 2026 announcing its second quarter 2026 financial results for the period ended July 3, 2026. The disclosure includes detailed quarterly financial metrics (sales, operating income, net income, EPS, EBITDA, and adjusted measures), product line performance, and year-to-date comparisons. This is a standard earnings release disclosure under Item 2.02, with the press release furnished as Exhibit 99.1. While the filing also mentions a pending KKR acquisition, the Item 2.02 section itself is focused on the quarterly earnings announcement.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing Compugen's second quarter 2026 financial results, including revenues of $2.6 million, R&D expenses of $6.3 million, and a net loss of $7.0 million ($0.07 per share). The document explicitly states "Compugen Reports Second Quarter 2026 Results" and includes condensed consolidated statements of operations and balance sheet data for the periods ended June 30, 2026 and 2025. This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance and cash runway into 2029.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This exhibit is a press release announcing MakeMyTrip's unaudited interim financial and operating results for fiscal 2027 first quarter ended June 30, 2026. It discloses revenue of $285.6 million (up 6.2% YoY, 16.1% in constant currency), profit for the period of $9.1 million (down 64.7% YoY), and detailed segment performance across air ticketing, hotels and packages, bus ticketing, and other services. The document includes comprehensive financial tables, segment analysis, and management discussion of results drivers. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
American Bitcoin Corp. issued a press release on August 3, 2026, announcing its financial results for the second quarter ended June 30, 2026, including revenue of $67.0 million, mining production of ~932 Bitcoin (record quarterly production), and strategic reserve growth to over 8,000 Bitcoin. The filing explicitly discloses this under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases on Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Indivior issued a press release on August 3, 2026 reporting Q2 2026 financial results for the period ended June 30, 2026, with total net revenue of $343 million (up 14% YoY), record SUBLOCADE net revenue of $253 million (up 21% YoY), record GAAP net income of $122 million, and record adjusted EBITDA of $186 million (up 111% YoY), along with raised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release (Exhibit 99.1) discloses quarterly financial results including R&D expenses ($24.6M), G&A expenses ($41.2M), net loss ($62.6M), and cash position ($427.3M), along with clinical and corporate progress updates. The filing explicitly states the press release is being furnished as Exhibit 99.1 in connection with the announcement of financial results for the quarter ended June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
BCB Bancorp issued a press release on August 3, 2026 reporting financial results for the second quarter ended June 30, 2026, including a net loss of $14.8 million, goodwill impairment of $5.3 million, asset quality deterioration, and elevated loan loss provisions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Hess Midstream LP issued a news release on August 3, 2026, reporting estimated results for the second quarter of 2026, including net income of $173.7 million, earnings per share of $0.75, Adjusted EBITDA of $313.7 million, and Adjusted Free Cash Flow of $231.6 million. The release also includes full-year 2026 guidance and operational highlights. This is a standard quarterly earnings disclosure furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Design Therapeutics issued a press release on August 3, 2026 announcing financial results for the three and six months ended June 30, 2026, including R&D expenses of $16.4 million, G&A expenses of $5.8 million, net loss of $20.2 million for Q2, and cash position of $207.4 million. The filing includes condensed statements of operations and balance sheets, which are standard components of quarterly earnings disclosures under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-03
EX-99.1
This is a clearly labeled "EARNINGS PRESS RELEASE" disclosing MakeMyTrip's unaudited financial and operating results for fiscal Q1 ended June 30, 2026. The exhibit presents key metrics including Gross Bookings growth of 19.9% YoY, Revenue growth of 16.1% YoY, and Adjusted Operating Profit, along with business highlights and management commentary. This is a discrete earnings announcement, not a periodic financial report, and would materially affect a reasonable investor's assessment of the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-08-03
Item 2.02
Warner Music Group disclosed preliminary estimated financial results for Q3 2026 (three months ended June 30, 2026), reporting consolidated revenue of $1,864 million (up 10%), operating income of $305 million (up 80%), Adjusted OIBDA of $433 million (up 16%), and EPS of $0.39 versus ($0.03) in the prior year, with an earnings conference call scheduled for August 5, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Stoke Therapeutics issued a press release on August 3, 2026 announcing financial results for the quarter ended June 30, 2026, including Q2 2026 revenue ($9.3M), net loss ($61.6M), R&D expenses ($49.5M), and SG&A expenses ($25.3M), along with year-to-date results. The disclosure is a standard quarterly earnings announcement with detailed financial metrics and business updates, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Adeia announced its second quarter 2026 financial results on August 3, 2026, disclosing revenue of $96.1 million, GAAP diluted EPS of $0.15, and adjusted EBITDA of $56.4 million. The press release also includes a significant increase in long-term annual revenue outlook from $500 million to $600 million, driven by confidence in the semiconductor business reaching $200 million in annual revenue. This is a standard quarterly earnings release with material financial results and forward guidance that would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
EverQuote issued a press release on August 3, 2026 reporting Q2 2026 financial results, including revenue of $195.1 million (25% growth), net income of $19.2 million, and record Adjusted EBITDA of $30.1 million, along with Q3 2026 guidance. The earnings release was furnished as Exhibit 99.1 and accompanied by an investor presentation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
ClearPoint Neuro issued a press release on August 3, 2026 announcing Q2 2026 financial results, reporting revenue of $10.9 million (18% growth), gross margin of 62%, operating expenses of $17.0 million, and revising full-year 2026 revenue guidance to $48.0–$52.0 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release disclosing Allison Transmission's second quarter 2026 financial results. The Item 2.02 disclosure explicitly states that "Allison published an earnings release reporting its financial results for the three months ended June 30, 2026" with the release attached as Exhibit 99.1. The release reports key metrics including net sales of $1,566 million (up 92% YoY), net income of $181 million, diluted EPS of $2.15, and adjusted EBITDA of $404 million, along with updated full-year 2026 guidance. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Ethos Technologies reported Q2 fiscal 2026 financial results (quarter ended June 30, 2026) with revenue of $189.6 million (113% YoY growth), net income of $19.5 million, and diluted EPS of $0.30, along with forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
TKO Group Holdings announced its financial results for Q2 2026 ended June 30, 2026, disclosing revenue of $1.547 billion, net income of $303.9 million, and Adjusted EBITDA of $649.9 million, along with raised full-year 2026 guidance. The press release (Exhibit 99.1) is the standard earnings announcement format with consolidated results, segment performance, and forward guidance, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
ORIC Pharmaceuticals issued a press release on August 3, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, including condensed balance sheets and statements of operations showing R&D expenses of $36.3 million (Q2 2026 vs. $30.5 million Q2 2025), G&A expenses of $9.0 million, and a net loss of $41.5 million. The disclosure is filed under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
SITE Centers Corp. disclosed quarterly financial results for Q2 2026 (quarter ended June 30, 2026) via a press release and quarterly financial supplement filed under Item 2.02. The disclosure includes consolidated income statements, FFO reconciliations, and detailed operating metrics. The company reported a net loss of $1.3 million ($0.03 per diluted share) and Operating FFO loss of $4.6 million ($0.09 per diluted share), along with significant property dispositions and a special dividend declaration. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Paymentus issued a press release on August 3, 2026 reporting unaudited financial results for the three and six months ended June 30, 2026 (Q2 2026). The disclosure includes record revenue of $360.7 million (up 28.8% YoY), net income of $25.6 million, adjusted EBITDA of $48.8 million (up 54.0% YoY with record 41.3% margin), and forward guidance for Q3 2026 and full-year 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Metallus issued a press release on August 3, 2026 announcing second-quarter 2026 financial results, including net sales of $341.0 million (up 12% year-over-year), net income of $8.9 million, and adjusted EBITDA of $29.0 million (up 9% year-over-year), along with detailed financial metrics, operational highlights, and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a clear earnings release disclosing Q2 2026 financial results for Offerpad Solutions Inc., including revenue of $77.7M, net loss of $9.3M, and Adjusted EBITDA of ($6.2M), along with forward guidance for Q3 2026. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes condensed consolidated financial statements and detailed operational metrics that would materially affect a reasonable investor's assessment of the company's financial condition and performance trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
FreightCar America issued a press release on August 3, 2026, announcing its second quarter 2026 financial results, including revenues of $113.1 million, net loss of $30.1 million, and updated fiscal 2026 guidance. The Item 2.02 disclosure explicitly states that a press release announcing financial results for Q2 2026 was issued and attached as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Crawford & Company issued a press release on August 3, 2026, disclosing its second quarter 2026 financial results, including revenues, net income, diluted earnings per share, segment performance, and cash flow metrics. The disclosure includes detailed GAAP and non-GAAP consolidated results tables and management commentary.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
SBA Communications issued a press release on August 3, 2026 announcing its financial and operational results for Q2 2026, including net income of $198.8 million ($1.87 per share), AFFO per share of $3.05, and updated full-year 2026 guidance. The filing explicitly states the company "issued a press release announcing its financial and operational results for the second quarter ended June 30, 2026, updating its full year 2026 guidance, and announcing its quarterly dividend," with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
This is a quarterly earnings release for Q2 2026 disclosing financial results for the period ended June 30, 2026. The filing explicitly states "CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results" and includes key financial metrics (CASGEVY revenue of $76 million with 78% QoQ and 151% YoY growth, R&D expenses of $67.2 million, net loss of $91.2 million, and cash position of $2,364.4 million), along with operational highlights and pipeline updates. The press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for results of operations and financial condition disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Innovex International disclosed Q2 2026 quarterly financial results via press release, reporting revenue of $245 million (up 9% year-over-year), net income of $25 million, adjusted EBITDA of $48 million, and free cash flow of $30 million, along with forward guidance for Q3 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
Item 2.02
Cabot Corporation issued a press release on August 3, 2026 announcing operating results for its fiscal quarter ended June 30, 2026, disclosing third quarter diluted EPS of $0.12 and Adjusted EPS of $1.67, along with segment EBIT results and updated fiscal 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, the designated item for results of operations and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-03
Item 2.02
Atlas Energy Solutions issued a press release on August 3, 2026 disclosing second quarter 2026 financial results, including total revenue of $293.2 million, net loss of $25.1 million, and Adjusted EBITDA of $49.5 million.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-03
The 6-K body explicitly states that "Attached as Exhibit I hereto is a copy of the press release of Capital Clean Energy Carriers Corp. announcing the financial results for the second quarter ended June 30, 2026." This is a discrete earnings announcement for Q2 2026, which is material to investors assessing the registrant's financial performance and is classified as an earnings_release event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 93%
filed 2026-08-03
Item 2.02
La Rosa Holdings issued a press release on August 3, 2026, announcing financial results for the fiscal quarter ended March 31, 2026, including revenue of $13.6M, gross profit of $2.0M (up 29.6% YoY), operating loss of $2.5M (improved 46.5% YoY), cash position, and digital asset holdings of $8.1M, along with condensed consolidated balance sheets and statements of operations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-03
The 8-K discloses Gulfport Energy's second quarter 2026 financial and operating results under Item 2.02, with a press release reporting net income of $87.1 million, adjusted EBITDA of $179.1 million, production of 962.8 MMcfe per day, and updated capital expenditure guidance. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-03
Item 2.02
Jazz Pharmaceuticals issued a press release on August 3, 2026 announcing second quarter 2026 financial results, including total revenues of $1.2 billion (+16% YoY), GAAP EPS of $2.78, and raised full-year 2026 revenue guidance to $4.60-$4.75 billion. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly discloses quarterly financial results, which is the hallmark of an earnings release.
View raw filing on EDGAR →